ZEISS Medical Technology in the news

Carl Zeiss Meditec (XTRA:AFX) is refining manufacturing analytics with a subsidiary's new purchase, while its stock shows short-term gains but long-term weakness and is considered undervalued despite challenges in the Chinese market.

Hyaltech, a Carl ZEISS Meditec company, acquired Nirrin Technologies' Atlas® system to modernize hyaluronic acid manufacturing with rapid spectroscopic analysis.

ZEISS Meditec's Hyaltech purchased an Atlas system from Nirrin Technologies to modernize its hyaluronic acid manufacturing workflows for ophthalmic viscosurgical devices.

Strategic partnerships and faster Chinese regulatory approval for the VISUMAX 800 laser have positioned the company for potential recovery despite recent long-term stock declines.

Leadership changes and the rollout of new intraocular lens technology define the current outlook despite lowered financial forecasts.

ZEISS and Envision Health Technologies are collaborating to implement VR-based, gamified visual function testing for earlier and more precise glaucoma detection.

Strategic collaboration with Envision Health Technologies to develop portable, gamified VR solutions for glaucoma screening and visual function testing.

Carl Zeiss is investing up to €200 million to increase its majority stake in Carl Zeiss Meditec as a show of confidence in the subsidiary's growth.

ZEISS Medical Technology is collaborating with Envision Health Technologies to advance virtual reality-based glaucoma diagnostics and improve patient accessibility.

Carl Zeiss AG will increase its stake in Carl Zeiss Meditec AG by up to 200 million Euros, reaffirming its long-term support while preserving independent operations and stock market presence.

Strategic partnership with Envision Health Technologies aims to advance glaucoma care through gamified virtual reality visual function testing.

Strategic partnership with Envision Health Technologies aims to advance glaucoma care through gamified virtual reality perimetry.

Strategic collaboration with Envision Health Technologies aims to advance glaucoma care through gamified virtual reality and portable visual function testing.

Strategic collaboration with Envision Health Technologies will introduce virtual reality-based visual function testing to improve glaucoma diagnostics and patient access.

ZEISS Medical Technology is collaborating with Envision Health Technologies to develop gamified VR-based vision testing for glaucoma care.

ZEISS and Envision Health Technology are collaborating to develop gamified VR solutions for more accessible and flexible glaucoma visual field testing.

ZEISS Medical Technology is delivering 25 VISUMAX 800 laser systems to Aier Eye Hospital Group to expand global refractive surgery capabilities.

ZEISS Medical Technology collaborates with Envision Health Technologies to advance glaucoma care through VR-based visual function testing, improving accessibility and clinical credibility.

Strategic partnership between ZEISS and Envision Health to develop virtual reality diagnostic tools for portable glaucoma screening.

ZEISS Medical Technology is collaborating with Envision Health Technologies to develop virtual reality-based solutions for glaucoma screening and visual function testing.